1290TiP - ALUR: a phase 3 study of alectinib versus chemotherapy in previously treated ALK+ non-small cell lung cancer (NSCLC)
| Autor: | Wolf, J., Oh, I.-J., Mazieres, J., de Castro, J., Revil, C., Kotb, A., Johansdottir, H., Zeaiter, A., Novello, S. |
|---|---|
| Zdroj: | In Annals of Oncology 1 October 2016 27 Supplement 6:vi449-vi449 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|